Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Non Operating Income data on file, last reported at $914000.0 in Q1 2026.

• On a quarterly basis, Non Operating Income fell 50.86% year-over-year to $914000.0 in Q1 2026; TTM through Mar 2026 was $5.0 million, a 54.19% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 211.42% from the prior year.
• Non Operating Income for Q1 2026 stood at $914000.0, down from $1.2 million in the prior quarter.
• Over the last five years, Non Operating Income for ARTV reached as high as $2.2 million in Q4 2024 and fell as low as -$1.7 million in Q2 2024.
• Historically, Non Operating Income has averaged $818500.0 across 4 years, with a median of $888500.0 in 2024.
• On a YoY basis, Non Operating Income climbed as much as 4836.36% in 2024 and fell as far as 406.11% in 2024.
• Year by year, Non Operating Income stood at $44000.0 in 2023, then jumped by 4836.36% to $2.2 million in 2024, then tumbled by 46.59% to $1.2 million in 2025, then fell by 21.21% to $914000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $914000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.